Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 23.90
-1.15 (-4.59%)
At close: Mar 3, 2026
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 3.89 billion as of March 3, 2026. Its market cap has increased by 4.16% in one year.
Market Cap
3.89B
Enterprise Value
5.01B
Revenue
113.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.90
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 3.89B, a decrease of -2.77%. That is a compound annual growth rate of -0.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 3.89B | 34.27% |
| Dec 31, 2025 | 2.90B | -20.37% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 4.58B |
| Senhwa Biosciences | 4.51B |
| Energenesis Biomedical CO.,LTD. | 4.49B |
| Formosa Pharmaceuticals | 4.20B |
| Medigen Biotechnology | 4.20B |
| ACRO Biomedical | 3.89B |
| BRIM Biotechnology | 3.62B |
| Genovate Biotechnology | 3.61B |